← Back to Search

Experimental: Pharmacist-Bidirectional Texting Group for High Blood Pressure

N/A

Waitlist Available

Led By Linnea A Polgreen, PhD

Research Sponsored by Linnea Polgreen

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months

Awards & highlights

Study Summary

This trial will test whether adding a pharmacist intervention to a bidirectional texting program is successful at decreasing subject blood pressure and increasing subject blood pressure treatment intensification in a cost-effective manner.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Systolic Blood Pressure- 12 Months

Secondary outcome measures

Change in Diastolic Blood Pressure- 12 Months

Dollars Spent per Patient for 12 Month Bidirectional Texting/Pharmacist Intervention

Number of Medication Changes in 12 Months

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Pharmacist-Bidirectional Texting GroupExperimental Treatment1 Intervention

Patients enrolled in the Pharmacist-Bidirectional Texting Group will return 7 morning and 7 evening blood pressure measurements via text message. The report will be shared with a pharmacist who will monitor them for 12 months. The pharmacist will have access to their entire medical record and will provide support and education via text messaging, email, or phone calls, whichever is preferred by the patient. The pharmacist will develop a care plan and make recommendations to the physician through the electronic medical record to quickly adjust therapy to improve control. They will also recommend laboratory testing if indicated. They will have contact with the patient every 2-3 weeks while blood pressure is uncontrolled, and at least every 2 months when it is controlled. The pharmacist will track all recommendations made to physicians and whether or not they were implemented, modified, or rejected.

Group II: Control GroupActive Control1 Intervention

Patients randomized to the control group will also return 7 morning and 7 evening blood pressure measurements. The report will be shared with a pharmacist who will call the patient to discuss the measurements and possibly recommend follow up with a physician, but no other pharmacist intervention or monitoring will occur during the 12 months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Linnea PolgreenLead Sponsor

3 Previous Clinical Trials

1,013 Total Patients Enrolled

National Heart, Lung, and Blood Institute (NHLBI)NIH

3,833 Previous Clinical Trials

47,305,963 Total Patients Enrolled

Linnea A Polgreen, PhDPrincipal InvestigatorUniversity of Iowa

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can seniors who are 65 years or older participate in this trial?

"The eligibility requirements of this research trial require that participants are between 21 and 100 years old. Notably, there is a total of 54 clinical trials available to people younger than 18 while 661 studies accomodate those over the age of 65."

Answered by AI

How many participants have joined the research endeavor thus far?

"Absolutely. As per clinicaltrials.gov, this healthcare research is actively looking for participants since its first posting on February 25th 2020 and last update in October 31st 2022. 420 individuals from a single site are needed to complete the trial successfully."

Answered by AI

What requirements must a person adhere to in order to participate in this research endeavor?

"This medical trial is recruiting 420 individuals aged between 21 and 100 who suffer from hypertension. The essential prerequisites are that they must be a patient of one of the 4 specified clinics, live in an area with RUCAs ranging from 4-10, and reside within certain zip codes."

Answered by AI

Are there any vacant spots in this medical research project?

"Affirmative, the information hosted on clinicaltrials.gov affirms that this research is actively accepting participants. This medical trial was first posted in February of 2020 and subsequently revised last October. The project seeks to include 420 patients at a single site location."

Answered by AI

Recent research and studies

Contemporary Clinical TrialsJournal

A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting: Pharmtext BP

Polgreen, Linnea A., Barry L. Carter, Philip M. Polgreen, Peter M. Snyder, Daniel K. Sewell, Emine O. Bayman, Shelby L. Francis, Jacob E. Simmering, Christopher Parker, and Rachel Finkelstein. 2020. “A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting: Pharmtext BP”. Contemporary Clinical Trials. Elsevier BV. doi:10.1016/j.cct.2020.106169.

clinicaltrials.govStudy

A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting

Linnea Polgreen 2020. "A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03986931.